| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| XKH-001(Xinkanghe Biomedical) | XKH-001 | Phase 2 Clinical | Beijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co Ltd | Allergic asthma; Asthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Inflammation; Pulmonary Disease, Chronic Obstructive | Details |